Woman Survives Pancreatic Cancer Twice After Doctor Dismissed Her Initial Symptoms

**Local Survivor Advocates for Awareness in Fight Against Pancreatic Cancer**

Rose Black, a resident of St. Clair Shores, Michigan, is making significant strides in raising awareness about pancreatic cancer following her own harrowing experiences with the disease. A two-time survivor, Black’s journey is not only a personal testament to resilience but also a call for others to advocate for their health.

Pancreatic cancer is notorious for its late-stage diagnosis due to vague symptoms that often go unnoticed. Black recalls troubling signs from her own body, including stomach bloating and unintended weight loss. Despite her efforts to communicate her concerns to her healthcare provider, she faced dismissal on two separate occasions, a common scenario for many patients. It was only after persistent advocacy on her part that a CT scan was finally ordered, which revealed the presence of a tumour.

Reflecting on her ordeal, Black noted the intense anxiety that accompanied her diagnosis. “At that time, pancreatic cancer meant a death sentence to most people,” she explained. Her initial surgery took place in 2009, marking the beginning of her long battle. However, her struggle did not end there, as the cancer returned in 2016. This prompted further treatment, including chemotherapy and a subsequent surgery.

Emphasising the importance of advocacy, Black shared her experience during an interview with local news station WXYZ. She highlighted the need for individuals, particularly women, to persist in seeking answers when their health is at stake. “I kept after him, and finally we found it,” Black said, reinforcing her belief that tenacity can lead to critical discoveries.

In 2011, Black and her husband Ron began volunteering with the Pancreatic Cancer Action Network (PanCAN), an organisation devoted to fighting the disease. Each year, PanCAN hosts PurpleStride, an event described as “the ultimate walk to end pancreatic cancer.” The organisation’s mission is not only to raise awareness but also to advocate for improved research funding and support for those diagnosed with the disease.

Renee Clearman, chairwoman of PurpleStride, spoke about the impact of their efforts, noting that the organisation aims to enhance the five-year survival rate for pancreatic cancer patients. Clearman, who lost her mother to the disease, remarked, “I’ve met and seen many survivors with many different stories, and the one common theme… is just that they’re positive, they’re advocating, they’re looking for trials, they are looking for options.”

The statistics concerning pancreatic cancer remain daunting, as symptoms often remain asymptomatic until the disease has significantly progressed, underscoring the importance of early detection. The Mayo Clinic asserts that while the five-year survival rate for pancreatic cancer is quite low, early diagnosis can greatly improve treatment options and outcomes.

Throughout her journey, Black has channelled her experiences into creating awareness and fostering community engagements. During her interview, she wore a special gift from PanCAN to signify her triumph as a double survivor. She articulated the importance of sharing personal stories, stating, “An important part of this is to be able to share your story and realise that you’re not alone out there.”

With the next PanCAN PurpleStride event scheduled for 26 April 2026, Black urges the community to participate and support the cause. Events will be hosted across the country, providing a platform for both survivors and advocates to come together, unite in their fight, and raise much-needed funds for research and support activities.

As Black continues her mission, she hopes to inspire others to take charge of their health and not shy away from pursuing necessary medical advice, irrespective of initial responses from healthcare professionals. Her story serves as a poignant reminder of the power of perseverance, and the critical role that advocacy plays in the fight against pancreatic cancer.